Equities
  • Price (USD)57.74
  • Today's Change2.05 / 3.68%
  • Shares traded13.53k
  • 1 Year change-10.38%
  • Beta--
Data delayed at least 15 minutes, as of Apr 23 2024 17:23 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
LONN:SWX since
announced
Transaction
value
Genentech Inc-Biologics Manufacturing Facility,Vacaville,CaliforniaAnnounced20 Mar 202420 Mar 2024Announced9.17%1.20bn
Synaffix BVDeal completed01 Jun 202301 Jun 2023Deal completed-7.55%171.01m
Data delayed at least 15 minutes, as of Apr 23 2024 16:33 BST.

Institutional shareholders

0.55%Per cent of shares held by top holders
HolderShares% Held
SBI Funds Management Ltd.as of 31 Mar 20243.59m0.48%
Manning & Napier Advisors LLCas of 29 Feb 2024143.33k0.02%
Torray Investment Partners LLCas of 31 Dec 2023110.05k0.02%
Zevin Asset Management LLCas of 31 Dec 202381.81k0.01%
Madison Asset Management LLCas of 31 Dec 202359.06k0.01%
Invesco Advisers, Inc.as of 29 Feb 202444.28k0.01%
Domini Impact Investments LLCas of 31 Jan 202425.20k0.00%
Causeway Capital Management LLCas of 04 Apr 202420.10k0.00%
Victory Capital Management, Inc. (Investment Management)as of 30 Nov 202317.15k0.00%
UBS Switzerland AG (Investment Management)as of 29 Dec 202316.37k0.00%
More ▼
Data from 31 Dec 2023 - 15 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.